Cardiac Design Labs Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 1.40 M
as on 18-07-2024
- Company Age 13 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -24.28%
(FY 2023)
- Profit 1220.03%
(FY 2023)
- Ebitda 26.86%
(FY 2023)
- Net Worth 5.36%
(FY 2023)
- Total Assets 37.96%
(FY 2023)
About Cardiac Design Labs
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.40 M, as per Ministry of Corporate Affairs (MCA) records.
Narendra Singh, Sashikumar Sreedharan, Anand Madanagopal, and One other member serve as directors at the Company.
- CIN/LLPIN
U33114KA2011PTC060867
- Company No.
060867
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Oct 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Cardiac Design Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Madanagopal  | Managing Director | 19-Oct-2011 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sashikumar Sreedharan | Director | 19-Oct-2011 | Current |
| Joseph Joseph | Nominee Director | 18-May-2018 | Current |
| Narendra Singh | Additional Director | 02-Nov-2013 | Current |
Financial Performance of Cardiac Design Labs.
Cardiac Design Labs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 24.28% decrease. The company also saw a substantial improvement in profitability, with a 1220.03% increase in profit. The company's net worth moved up by a moderate rise of 5.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cardiac Design Labs?
In 2023, Cardiac Design Labs had a promoter holding of 68.12% and a public holding of 31.88%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cyient Solutions And Systems Private LimitedActive 7 years 9 monthsJoseph Joseph is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cardiac Design Labs?
Cardiac Design Labs has a workforce of 12 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cardiac Design Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cardiac Design Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
